Last reviewed · How we verify

NCT03710980

Accuracy of Pulse Oximeters With Profound Hypoxia

Completed Last updated 18 October 2018
What this trial tests

trial testing Oximeter in Oximetry in 12 participants. Completed in 19 September 2018.

Timeline
18 September 2018
Primary endpoint
19 September 2018
19 September 2018

Quick facts

Lead sponsorHancock Medical, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment12
Start date18 September 2018
Primary completion19 September 2018
Estimated completion19 September 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Hancock Medical, Inc.

Who can join

Adults 18 to 50, any sex, with Oximetry. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study to assess the oxygen saturation accuracy of the Beddr SleepTuner in profound hypoxia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hancock Medical, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03710980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing